文献速递乳房整形与再造美容整形

中央腺体蒂乳房缩小术:安全有效的技术

The Central Mound Pedicle: A Safe and Effective Technique for Reduction Mammaplasty.
PubMed 文献 · Plast Reconstr Surg · 2020-01-01

共552侧乳房)。结果显示并发症率低,双侧巨乳患者BREAST-Q评分显著改善,表明该技术安全有效。

要点

  • 中央蒂乳房缩小术适用于双侧巨乳和单侧对称性缩小。
  • 总体并发症率低,血清肿0.2%、血肿1.1%、感染1.5%。
  • 双侧巨乳患者BREAST-Q评分显著改善。

核心结论

  • 中央腺体蒂是双侧巨乳和单侧对称性乳房缩小术的安全有效方法。

主要发现

  • 平均年龄46岁,平均BMI 27.4 kg/m²。
  • 双侧巨乳患者平均手术时间3小时34分钟,平均切除组织右乳533g、左乳560g。
  • 所有患者平均随访169天。
  • 每侧乳房并发症率:血清肿0.2%、血肿1.1%、裂开2.9%、感染1.5%、增生性瘢痕4.6%、乳头坏死0.4%、脂肪坏死0.9%、皮瓣坏死1.7%。
  • 双侧巨乳患者BREAST-Q缩小/乳房固定问卷(Likert 1-5分)所有评分显著改善。

临床怎么用

  • 中央蒂技术可用于双侧巨乳缩小和单侧对称性缩小,并发症风险低。
  • 术后应关注血清肿、血肿、裂开、感染、瘢痕增生、乳头及皮瓣坏死等并发症。
  • 可使用BREAST-Q评估患者报告结局。

局限性

  • 回顾性研究,证据等级IV。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The central mound technique offers a relatively less common approach for breast reduction. This study evaluated the expected safety and efficacy outcomes using this technique in a large patient series. METHODS: A retrospective review of all patients undergoing central mound breast reduction at the authors' institution between June of 1999 and November of 2018 was performed. Both bilateral macromastia and unilateral symmetrizing reduction patients were included but evaluated separately for some outcomes. Patient demographics and comorbidities, operative details, postoperative adverse events, and BREAST-Q scores were recorded. Associations between preoperative variables and outcomes were assessed with chi-square tests, Wilcoxon tests, and Kendall tau-b correlations. RESULTS: A total of 325 patients were identified for inclusion (227 bilateral and 98 unilateral; 552 breasts). The average patient age was 46 years, and the average body mass index was 27.4 kg/m. Among the bilateral macromastia patients, the average operative time was 3 hours 34 minutes, and average breast tissue removed was 533 g (right breast) and 560 g (left breast). Among all patients, average follow-up was 169 days. On a per-breast basis for all patients, the following complication rates were observed: seroma, 0.2 percent; hematoma, 1.1 percent; dehiscence, 2.9 percent; infection, 1.5 percent; hypertrophic scar, 4.6 percent; nipple necrosis, 0.4 percent; fat necrosis, 0.9 percent; and skin flap necrosis, 1.7 percent. Using the BREAST-Q Reduction/Mastopexy questions on a Likert scale ranging from 1 to 5, restricted to the bilateral macromastia patient population, all scores improved with statistical significance. CONCLUSION: The central mound pedicle is a safe and effective approach for reduction mammaplasty for both bilateral macromastia patients and unilateral symmetrizing operations. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. DeLong MR, Chang I, Farajzadeh M, et al. The Central Mound Pedicle: A Safe and Effective Technique for Reduction Mammaplasty. Plast Reconstr Surg. 2020. PMID: 32590526. doi:10.1097/PRS.0000000000007173

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。